Penehyclidine is an anticholenergic , bronchodilator, antimuscarinic and antinicotinic agent. Penehyclidine was developed by Chengdu List Pharmaceutical Co.Ltd.
The API has now reached off-patent status, after being launched in 2002.

The information provided above is sourced from Chemrobotics PharmaVetPat https://chemroboticspharma.com/pharmVetPat
to find out more, including patent landscape and routes of synthesis, please contact our sales team.

For enquiries regarding more detailed trade data of Penehyclidine and many others, contact info@pharmacheminvestor.com